Acorda Therapeutics reported $76.52M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 532.52M 9.7M
Acorda Therapeutics ACOR:US $ 76.52M 3.93M
Agios Pharmaceuticals AGIO:US $ 870.01M 105.14M
ALKERMES ALKS:US 1.05B 31.16M
Amgen AMGN:US $ 19322M 802M
Anika Therapeutics ANIK:US $ 167.86M 2.53M
Arrowhead Research ARWR:US $ 432.39M 14.76M
Biogen BIIB:US $ 9740.9M 1825M
Biomarin Pharmaceutical BMRN:US $ 2517.6M 123.57M
Cara Therapeutics CARA:US $ 176.17M 24.4M
Clovis Oncology CLVS:US $ 142.28M 43.25M
Cytokinetics CYTK:US $ 602.25M 21.28M
Enanta Pharmaceuticals ENTA:US $ 313.04M 28.83M
Gilead Sciences GILD:US $ 13705M 1076M
GlaxoSmithKline GSK:LN 54.19B 25.2B
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Insmed INSM:US $ 674.73M 81.41M
Ligand Pharmaceuticals LGND:US $ 243.78M 32.28M
Mannkind MNKD:US $ 184.26M 35.48M
Merck MRK:GR € 12416M 1331M
Moderna Inc MRNA:US 13.56B 2.79B
Neurocrine Biosciences NBIX:US $ 1019.3M 1.1M
Novartis NOVN:VX 38.14B 906M
Teva Pharmaceutical TEVA:IT 12.16B 287M
Ultragenyx Pharmaceutical RARE:US $ 678.54M 28.98M
Vertex Pharmaceuticals VRTX:US $ 11503.5M 1142.2M